Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment

Por Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Marina V. Shestakova, Larisa V. Nikankina, Natalia S. Fedorova
Publicado em 2019-12-01

TGF-β and FRF-21: association with coronary artery disease in patients with type 2 diabetes and obesity

Por Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Larisa V. Nikankina, Svetlana S. Kukharenko, Marina V. Shestakova
Publicado em 2017-11-01

Profile of microRNAs associated with coronary heart disease in patients with type 2 diabetes

Por Teona A Shvangiradze, Irina Z Bondarenko, Ekaterina A Troshina, Marina V Shestakova, Alexander V Ilyin, Larisa V Nikankina, Aleksandr V Karpukhin, Tat'yana A Muzaffarova, Fatimat M Kipkeeva, Kristina A Grishina, Anna Yu Kuzevanova
Publicado em 2016-12-01

Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults)

Por Ivan I. Dedov, Galina A. Mel'nichenko, Marina V. Shestakova, Ekaterina A. Troshina, Natalya V. Mazurina, Ekaterina A. Shestakova, Yuriy I. Yashkov, Alexander E. Neimark, Elena V. Biryukova, Irina Z. Bondarenko, Natalia S. Bordan, Fatima H. Dzgoeva, Ekaterina V. Ershova, Kseniya A. Komshilova, Ashot M. Mkrtumyan, Nina A. Petunina, Tatiana I. Romantsova, Elena G. Starostina, Leonid G. Strongin, Ludmila A. Suplotova, Valentin V. Fadeyev
Publicado em 2018-04-01